IGC Pharma (IGC) Total Liabilities (2011 - 2026)
IGC Pharma (IGC) posted quarterly Total Liabilities of $3.1 million for Q1 2026, up 26.77% year-over-year from $2.4 million in Q1 2025, and up 33.86% quarter-over-quarter from $2.3 million in Q4 2025.
IGC Pharma (IGC) Total Liabilities (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Total Liabilities for 16 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 26.77% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 26.77% YoY), while the FY2026 annual figure was $3.1 million, up 26.77% from the prior year.
- Total Liabilities rose to $3.1 million in Q1 2026 per IGC's latest filing, from $2.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $3.1 million in Q1 2026 and bottomed at $1.7 million in Q3 2025.
- Historically, Total Liabilities has averaged $2.4 million across 5 years, with a median of $2.4 million in 2023.
- Annual changes were most pronounced in 2023 — Total Liabilities surged 32.75% — and 2025, when it tumbled 44.82%.
- IGC Pharma's Total Liabilities stood at $1.8 million in 2022, then advanced by 25.84% to $2.2 million in 2023, then gained by 27.79% to $2.8 million in 2024, then dropped by 18.8% to $2.3 million in 2025, then surged by 33.86% to $3.1 million in 2026.
- Business Quant data shows IGC's Total Liabilities at $3.1 million in Q1 2026, $2.3 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.06 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Mar 31, 2022 | 2.94 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 2.71 Mn |